Company / Free Cash Flow
Biohaven Ltd. Free Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$586.5M
FY2024
5-year range
-$586.5M / -$77.1M
FY2020-FY2024
Trend
-75.2%
vs FY2023
Sector context
#188 of 194
Health Care
What the data says
Among 194 Health Care companies, Biohaven Ltd. is in the bottom 3% for free cash flow. Free Cash Flow has declined for 4 consecutive years, from -$77M in FY2020 to -$587M in FY2024.
Based on SEC 10-K filings.
-$587M in FY2024.
Declined from -$304M to -$587M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 194This company -$586.5M Sector average $470.8M
▼
-224.6% below sector average
Key checks
Key Insights
- Biohaven Ltd.'s free cash flow has declined for 4 consecutive years.
- In FY2024, free cash flow decreased 75.2% year-over-year.
- Ranks #188 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$586.5M | -75.2% |
| FY2023 | -$334.8M | -10.2% |
| FY2022 | -$303.8M | -107.0% |
| FY2021 | -$146.8M | -90.5% |
| FY2020 | -$77.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026